Synergistic effect of quinacrine in combination with decitabine for the treatment of acute myeloid leukemia cells in vitro: implication for treatment of AML in the elderly

被引：0
|
作者：
Wang, Wenge [1 ]
Dicker, David T. [2 ,3 ]
Claxton, David F. [1 ]
Wang, Hong-Gang [4 ]
El-Deiry, Wafik S. [2 ,3 ]
机构：
[1] Penn State Hershey Med Ctr, Inst Canc, Hematol Oncol, Hershey, PA USA
[2] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[3] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
[4] Penn State Coll Medicne, Dept Pediat, Hershey, PA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3486
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3486
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients
    Staib, P
    Lathan, B
    Knoppel-Schwark, S
    Tesch, H
    Voliotis, D
    Steinmetz, HT
    Schwonzen, M
    Wickramanayake, PD
    Diehl, V
    ANNALS OF ONCOLOGY, 1998, 9 (02) : 221 - 223
  • [42] INTENSIVE TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML)
    MULDER, NH
    DEVRIES, EGE
    HOUWEN, B
    NETHERLANDS JOURNAL OF MEDICINE, 1980, 23 (04): : 179 - 179
  • [43] Treatment Practices in Older Adults with Acute Myeloid Leukemia (AML)
    Lee, Andrea J.
    Lyden, Elizabeth R.
    Chintalacheruvu, Lakshmi Manogna
    Thuy Thi Koll
    Maness, Lori J.
    Gundabolu, Krishna
    Bhatt, Vijaya R.
    BLOOD, 2017, 130
  • [44] 10-Day Low Dose Decitabine Regimen for Elderly Acute Myeloid Leukemia Patient Maintenance Treatment
    Liu, Jia
    Kong Peiyan
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Yan, Hongju
    Zhu, Lidan
    Gao, Shichun
    Lei, Gao
    Zeng, Defu
    Zhang, Xi
    BLOOD, 2018, 132
  • [45] Updated Safety and Efficacy of Venetoclax with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia
    DiNardo, Courtney D.
    Pollyea, Daniel A.
    Jonas, Brian A.
    Konopleva, Marina
    Pullarkat, Vinod
    Wei, Andrew
    Kantarjian, Hagop M.
    Pigneux, Arnaud
    Recher, Christian
    Seymour, John F.
    Dunbar, Martin
    Xu, Tu
    Mabry, Mack
    Potluri, Jalaja
    Pratz, Keith
    Letai, Anthony
    BLOOD, 2017, 130
  • [46] DECITABINE AS THE FIRST-LINE TREATMENT FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA; A SINGLE CENTER EXPERIENCE IN KOREA
    Lee, J.
    Park, H.
    Cho, H.
    Jang, J.
    Kim, S. J.
    Kim, Y.
    Kim, J. S.
    Cheong, J. W.
    Min, Y. H.
    HAEMATOLOGICA, 2015, 100 : 658 - 658
  • [47] Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
    He, Pin-Fang
    Zhou, Jing-Dong
    Yao, Dong-Ming
    Ma, Ji-Chun
    Wen, Xiang-Mei
    Zhang, Zhi-Hui
    Lian, Xin-Yue
    Xu, Zi-Jun
    Qian, Jun
    Lin, Jiang
    ONCOTARGET, 2017, 8 (25) : 41498 - 41507
  • [48] EFFECT OF MULTIPOTENT MESENCHYMAL STROMA CELLS (MSC) ON ACUTE MYELOID LEUKEMIA (AML) CELLS IN VITRO AND IN VIVO
    Schelker, Roland C.
    Mueller, Gunnar
    Hart, Christina
    Klatt, Sabine
    Herr, Wolfgang
    Grassinger, Jochen
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S94 - S94
  • [49] Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
    Young, Christine S.
    Clarke, Kathryn M.
    Kettyle, Laura M.
    Thompson, Alexander
    Mills, Ken I.
    ONCOTARGET, 2017, 8 (31) : 51429 - 51446
  • [50] Decitabine in acute myelogenous Leukemia (AML) Non-intensive but effective Treatment Option for AML Patients
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (11) : 741 - 741
12345